Health Sciences Group, Inc.
Health Sciences Group, Inc. (HESG) Revenue
Annual & quarterly revenue history · segment & region breakdown
HESG · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsHealth Sciences Group, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 495.98% year-over-year from $0.00B in FY2012.
Revenue trend
2012 – 2000 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2012-12-31 | $0.00B | +$0.00B | +495.98% |
| 2005-12-31 | $0.00B | -$0.00B | -10.51% |
| 2004-12-31 | $0.00B | -$0.01B | -98.75% |
| 2003-12-31 | $0.01B | -$0.00B | -3.12% |
| 2002-12-31 | $0.01B | +$0.01B | +1520.18% |
| 2001-12-31 | $0.00B | +$0.00B | — |
| 2000-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Health Sciences Group, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Health Sciences Group, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Health Sciences Group, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HESG revenue · 4 questionsHESG's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 495.98% year-over-year from $0.00B in FY2012.
▸ Source: FMP · Health Sciences Group, Inc. SEC filings · GAAP · Health Sciences Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026